Times of IndiaBeware of fluctuating food habitsTimes of IndiaHormones are affected – May lead to irritability and anger – Could cause constipation/diarrhoea – It affects skin and hair – It could affect your bone health – Affects your energy levels – Co…
Dobson organ donor bill is under threat – Portadown Times
Portadown TimesDobson organ donor bill is under threatPortadown TimesI thought that changes to organ donation laws would be one we could all get behind. Indeed, the aim of my bill which is to move Northern Ireland to a soft opt-out system has been publ…
Arts and Entertainment this weekend and looking ahead, updated Jan. 24 – TCPalm
|
Arts and Entertainment this weekend and looking ahead, updated Jan. 24
TCPalm Concert Series: James David Christie, organ, and Daniel Rios, English horn. 4 p.m. Jan. 26. Community Church of Vero Beach, 1901 23rd St., Vero Beach. Offering. …. Kevin McCullers: 6 p.m. Jan. 27. Capt. Hiram’s, 1606 Indian River Drive, Sebastian … |
Channel swim death of Susan Taylor due to heart failure, inquest told – Leicester Mercury
Leicester Mercury |
Channel swim death of Susan Taylor due to heart failure, inquest told
Leicester Mercury The desperate attempts to save the life of a “wonderful and caring” woman who got into difficulty as she neared the end of a cross-Channel swim have been revealed at her inquest. Susan Taylor, of Barwell, was a mile from the French shore when she began … |
Novartis still sees heart failure blockbuster after EU blow – Economic Times
Economic Times |
Novartis still sees heart failure blockbuster after EU blow
Economic Times “Novartis announced today it will shortly submit a revised filing package, including new data analyses, for re-examination for conditional approval of RLX030, or serelaxin,” the Basel-based drugmaker said in a statement. Novartis Denied EU’s Nod for Heart-Failure Drug Serelaxin (3)Businessweek UPDATE 2-Novartis still sees heart failure blockbuster after EU blowReuters Novartis to request re-examination of serelaxin (RLX030) in acute heart …FiercePharma Reuters India –RTT News all 26 news articles » |
Use of twice-daily pill could turn deadly blood cancer into highly treatable … – News-Medical.net
Drug Discovery & Development |
Use of twice-daily pill could turn deadly blood cancer into highly treatable …
News-Medical.net They found that those who received the combination of idelalsib and rituximab went longer without their disease worsening than those who received only rituximab, which has been the standard of care. Six months into the study, cancers in 93 percent of … New pill can ‘melt away’ leukemia without chemotherapyZee News A pill may replace chemotherapy in treating leukemiaBusiness Standard |
Idelalisib test results suggest CLL may be treated without toxic chemotherapy – News-Medical.net
Idelalisib test results suggest CLL may be treated without toxic chemotherapyNews-Medical.netThey found that those who received the combination of idelalsib and rituximab went longer without their disease worsening than those who received only rituxima…
Novartis Denied EU Panel Nod for Serelaxin Heart Drug – Bloomberg
Novartis Denied EU Panel Nod for Serelaxin Heart DrugBloombergNovartis AG (NOVN) failed to win backing from a European advisory panel for its Serelaxin treatment for acute heart failure, a product that had potential to garner as much as $1 billion in a…
IMS-BHU docs perform rare lung surgery – Times of India
IMS-BHU docs perform rare lung surgeryTimes of IndiaVARANASI: The doctors at the department of cardiology, Institute of Medical Sciences (IMS), recently performed a video-assisted thoracoscopic surgical (VATS) lung biopsy for the diagnosis of suspected…
3000 NI elderly survive cancer for at least 10 years – BBC News
|
3000 NI elderly survive cancer for at least 10 years
BBC News Brian Coburn, from Banbridge in County Down, was 69 when he was diagnosed with multiple myeloma, and at the time was one of the oldest people in Northern Ireland to undergo a stem cell transplant at Belfast City Hospital. Mr Coburn, now 78, said: “At … |